This article has a correction

Please see: Evid Based Med 2013;18:120

Evid Based Med 18:27-28 doi:10.1136/eb-2012-100735
  • Therapeutics
  • Randomised controlled trial

A small proportion of people with dementia and neuropsychiatric symptoms experience clinically significant worsening when antidepressants are discontinued

  1. Anne Corbett2
  1. 1King's College London, London, UK
  2. 2Alzheimer's Society, London, UK
  1. Correspondence to: Clive Ballard
    Wolfson Centre for Age-Related Diseases, Wolfson Wing, Hodgkin Building, King's College London, Guy's Campus, London SE 1 1UL, UK; clive.ballard{at}

Commentary on:


Depression is common in dementia with prevalence over 20%,1 causing distress, reducing quality of life, exacerbating impairment, increasing mortality and increasing caregiver stress.2 Treating depression is a clinical priority to improve well-being, quality of life and function in people with dementia. Depression may also underpin other neuropsychiatric symptoms such as agitation.3 The overall evidence does not, however, suggest that antidepressants are an effective treatment for depression in Alzheimer's disease (AD),4–6 although there is preliminary evidence for potential benefits of some antidepressants …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBM.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article